Skip to main content
TipRanks
Go Ultimate75% OFF

ImmuPharma (IMM) Income Statement

34 Followers

ImmuPharma Income Statement

Last quarter (Q2 2026), ImmuPharma's total revenue was £0.00. In Q2, ImmuPharma's net income was £-4.70M. See ImmuPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
£ 0.00£ 0.00£ 0.00£ 0.00£ 118.35K
£ -35.30K£ -63.88K£ -37.61K£ -118.00K£ 118.35K
£ 2.51M£ 2.67M£ 3.06M£ 2.91M£ 6.71M
Depreciation and Amortization£ 35.30K£ 63.88K£ 37.61K£ 117.56K£ 114.12K
£ -2.51M£ -2.61M£ -3.02M£ -2.91M£ -8.70M
£ -2.54M£ -2.68M£ -3.06M£ -3.03M£ -6.59M
£ 370.56K£ -104.00K£ -356.00K£ -1.43M£ -2.35M
£ -2.17M£ -2.78M£ -3.42M£ -4.46M£ -8.94M
£ -1.81M£ -2.48M£ -2.92M£ -3.81M£ -8.17M
Per Share Metrics
Basic EPS£ -0.00£ -0.01£ -0.01£ -0.01£ -0.03
Diluted EPS£ -0.00£ -0.01£ -0.01£ -0.01£ -0.03
Weighted Average Shares Outstanding490.59M413.92M360.71M302.91M251.16M
Weighted Average Shares Outstanding (Diluted)490.59M416.44M362.00M302.91M251.16M

Currency in GBP

ImmuPharma Earnings and Revenue History

-10M-5M05M-10000 %-7500 %-5000 %-2500 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin